6th Exosome-Based Therapeutic Development Summit

Kongressthemen
Now more than ever, exosome and EV therapies are on the verge of groundbreaking clinical and commercial breakthroughs. With recent milestones like Aegle Therapeutics' clinical advances, Kimera Labs' FDA approval, Capricor Therapeutics' collaboration on a COVID vaccine with the NIH, and NurExone Biologics' innovations in CNS treatments, this summit is a must-attend event.

Wissenschaftliche Fach-Gesellschaft
Hanson Wade

Anmerkungen
Brochure: https://go.evvnt.com/2433871-3?pid=4832

Speakers: AJ Bergmann Chief Financial Officer Capricor Inc., Banishree Saha Associate Director Takeda Pharmaceutical Co. Ltd., Carla Mazzeo Research and Development Director Regenerelle and More.

https://go.evvnt.com/2433871-2?pid=4832

Frau Erin Thomas